Active Pharmaceutical Ingredients
| PRODUCT | CAS NO | PHARMACOPOEIA | THERAPEUTIC CATEGORY | STATUS |
|---|---|---|---|---|
| Ursodeoxycholic Acid | 128-13-2 | IP/USP/EP/BP | Cholelithiasis Agent | Commercialised(DMF available) |
| Phenylephrine Hydrochloride (Oral and Injectable) | 61-76-7 | IP/USP/EP/BP | Decongestant | Commercialised(CEP Filed) |
| Pentazocine | 359-83-1 | IP/USP/BP | Analgesic | Commercialised(Tech Pack Available) |
| Dapagliflozin Propanediol | 960404-48-2 | USP | Antidiabetic | Commercialised(DMF Available) |
| Dexketoprofen Trometamol (Oral and Injectable) | 156604-79-4 | In-House | Anti-Inflammatory | Commercialised(DMF Available) |
| Ketoprofen | 22071-15-4 | USP/EP | Anti-Inflammatory | Commercialised |
| Citicoline Sodium (Oral and Injectable) | 33818-15-4 | IP/USP | Psychostimulant | Commercialised |
| Fexofenadine Hydrochloride | 153439-40-8 | IP/USP/EP/JP | Antihistaminic | Commercialised |
| Tapentadol Hydrochloride | 175591-09-0 | IP/EP | Analgesic | In Pipeline |
| Lisdexamfetamine Dimesylate | 608137-33-3 | In-House | CNS Stimulant | In Pipeline |
| Montelukast Sodium | 151767-02-1 | IP/USP/EP | Anti-Asthmatic | In Pipeline |
| Empagliflozin | 864070-44-0 | IH | Antidiabetic | In Pipeline |
| Nebivolol Hydrochloride | 152520-56-4 | IP/USP/EP | Antihypertensive | In Pipeline |
| Quetiapine Fumarate | 111974-72-2 | IP/USP/EP | Antipsychotic | In Pipeline |
| Mirabegron | 223673-61-8 | BP/EP | Antispasmodic | In Pipeline |
| Vonoprazan Fumarate | 881681-01-2 | IH | Antiulcerative | In Pipeline |
| Tranexamic Acid | 1197-18-8 | IP/USP | Antifibrinolytic | In Pipeline |
| Tolvaptan | 150683-30-0 | IP | Diuretic | In Pipeline |
Intermediates
| PRODUCT | CAS NO | END USE | INTERMEDIATE CODE | STATUS |
|---|---|---|---|---|
| Phenylephrine Base | 59-42-7 | Phenylephrine | PHP Base | Commercialised |
| 3 -Hydroxyacetophenone | 121-71-1 | Phenylephrine | 3-HAP | Commercialised |
| 2-[benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride | 71786-67-9 | Phenylephrine | - | Commercialised |
| 3-Nitroacetophenone | 121-89-1 | Phenylephrine | 3-NAP | Commercialised |
| Fexofenadine Base | 83799-24-0 | Fexofenadine | Fex Base | Commercialised |
| Methyl 2-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoate | 154477-55-1 | Fexofenadine | Fex X/ D10 | Commercialised |
| L-proline benzyl ester hydrochloride | 16652-71-4 | Lisinopril | LIS-3 | Commercialised |
| Phenylacetone | 103-79-7 | Lisdexamfetamine | - | In Pipeline |
| 7-Ethyltryptophol | 41340-36-7 | Etodolac | - | In Pipeline |
| Diethyl 2,2,14,14-tetramethyl-8-oxopentadecanedioate | 738606-43-4 | Bempedoic Acid | - | In Pipeline |
| 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid | 413624-71-2 | Bempedoic Acid | - | In Pipeline |
**These products are not available for sale in countries where the patents are applicable or still valid